Optogenerapy > Consortium

Led by Eurecat – Centre Tecnológic de Catalunya (Barcelona, Spain), the Optogenerapy top-class consortium comprises 11 partners from 7 European countries. The team integrates research, clinics, manufacturing expertise and Medical Device market knowledge, ensuring that the preclinically validated prototype obtained at the end responds to market demands.


Eurecat is the leading Technology Centre of Catalonia. It provides the industrial and business sector with differential technology and advanced expertise, offers solutions to their innovation needs and boosts their competitiveness in a fast-paced environment. With a vast expertise in injection moulding processes, Eurecat will be responsible for the industrial manufacturing of the micro medical device and the implant optoelectronics.



ETH-Zurich is one of the leading international universities for technology and the natural sciences and the only developer of optogenetic cell-based implants worldwide. With the primary concern to transfer its knowledge to the private sector and society at large, ETH Zurich will lead the wireless-powered optogenetic implant architecture development and the stable cell line engineering.


Politechnika Lodzka

Politechnika Lodzka (the Lodz University of Technology) is among the leaders in Polish and international universities in research on numerous areas of science and technology. The Institute of Applied Radiation Chemistry (IARC), with experts on sterilization and biocompatibility for advanced biomaterials and medical devices, will be directly involved in the project and responsible for selecting the most appropriate sterilization method for the device and coordinate preclinical validation.


Erasmus Universiteit Rotterdam

Erasmus University Rotterdam (ERASMUS) is a university in Rotterdam, the Netherlands, with 3,700 academic staff members and 23,867 students. Recognized for their independent research on medical technology assessment and socio-economic studies of medical devices, they will address the main socio-economic aspects of the project from the perspective of the payer and the patient.



GeneXplain is a system modelling SME offering one of the very few systems world-wide enabling causative interpretation of signal transduction pathways, of major interest for developing optogenetics cell therapies. GeneXplain will contribute to the development of suitable in-silico modelling tools to assist the therapeutic cell line development of the optogenetic pathway activation.

Twoptics Systems Design

Twoptics Systems Design is an optical systems design and engineering firm, founded by experienced professionals in optomechanical engineering and optics business accumulating over 20 years of technical and business experience. The company is in charge of optical design, development and integration inside the chip of the light transport system, which will ensure a homogeneous illumination of the cell chamber.


NEOS Surgery

NEOS Surgery is a highly innovative technology-based SME dedicated to the development and commercialization of medical devices for application in both cranial and spinal neurosurgery. Founded in 2003, the company will be focused on the surgical aspects of the implant to be developed.



Ultrasion is a technology-based spin-off with the aim of designing, manufacturing and commercializing worldwide industrial solutions based on high-power ultrasounds. The company will be involved in the development of the implant manufacturing process and will adapt its unique micro-moulding technology to address in-mould integration of the optoelectronics and membranes to the implant.

Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices. For more than 30 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. Boston Scientific will perform the system integration and ensure that the prototype includes considerations for successful market introduction



Created in 1964, the Institut National de la Santé et de la Recherche Médicale (INSERM) is a public scientific and technological structure placed under the control of both French Ministry of Health and Ministry of Research. Both the Neurodegenerative Diseases and Multiple Sclerosis Clinic group will participate in the project providing clinical know-how on Multiple Sclerosis patients’ needs and sharing their knowledge on cell and gene therapies for neurodegenerative diseases.



The Spanish Association for Standardization, UNE, is a non-profit-making, private, independent and multisector organization that helps improve the quality and competitiveness of companies, products and services. Representing the European CEN/CENELEC and the international ISO/IEC for the development of technical standards, UNE will advise, manage and develop all activities related with standardization.

Do NOT follow this link or you will be banned from the site!